VRDN Stock Analysis: Buy, Sell, or Hold?
VRDN - Viridian Therapeutics, Inc. Common Stock
$18.53
-8.86 (-32.35%)
▼
5d:
-32.91%
30d:
-36.93%
90d:
-41.88%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
VRDN is down 4.2% this week, but smart money is accumulating calls. Top strike: $28 2026-05-15 with 4 OI. Call ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When VRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VRDN is down 32.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VRDN is down 32.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VRDN is currently trading at $18.53, which is considered oversold relative to its 30-day fair value range of $26.15 to $30.26.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $16.97, while resistance sits at $29.32. Short-term momentum is weak, with the stock down 32.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.76 (+125.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $16.97, while resistance sits at $29.32. Short-term momentum is weak, with the stock down 32.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.76 (+125.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$26.15 -
$30.26
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding VRDN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-32.3%)
- BULLISH: Trading 125.4% below Wall St target ($41.76)
- WARNING: Recommendation downgraded due to -32.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$26.15 -
$30.26
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$16.97
Resistance Level
$29.32
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.04
Wall Street Target
$41.76
(+125.4%)
Revenue Growth (YoY)
83.3%
Share & Embed Analysis
Last updated: March 31, 2026 12:21 AM ET
Data refreshes hourly during market hours. Next update: 1:21 AM
Data refreshes hourly during market hours. Next update: 1:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRDN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Jennifer Tousignant
SELL
2272 shares
2025-12-31
Fairmount Funds Manageme…
BUY
454545 shares
2025-10-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 45 HOLD |
Advanced VRDN Option Strategies
Professional options setups generated by AI based on today's VRDN price and gamma walls.
